New hope for kids with tough leukemia: drug combo trial opens
Disease control
Recruiting now
This early-stage trial tests whether adding the drug talazoparib to standard chemotherapy is safe for children and young adults up to age 21 whose acute myeloid leukemia (AML) has come back or not responded to treatment. The study will first find the safest dose of the combinatio…
Phase: PHASE1 • Sponsor: Norman J. Lacayo • Aim: Disease control
Last updated May 06, 2026 16:02 UTC